from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2834c/ugpE

LFCtreatmentdescriptionclass of inhibitor

-0.753

Amikacinug/mL Amikacintranslation

1.583

Cap5-10ug/mL Capreomycintranslation

0.641

Rox10-50 ug/mL Roxithromycintranslation

-0.070

SM2-5 ug/mL Streptomycintranslation

-1.014

Tet5-10 ug/mL Tetracyclinetranslation

1.317

Rif0.2-5ug/mL Rifampicintranscription

0.512

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.652

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.002

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.258

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.782

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.230

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.381

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.360

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.233

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.348

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.125

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.143

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.471

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.609

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.329

KCN5-20 ug/mL Potassium cyaniderespiration

-0.207

NaN30.2-2 mM Sodium aziderespiration

-0.329

Nigericin50 uM Nigericinrespiration

-0.310

TRC10-150 ug/mL Triclosanrespiration

-0.687

TRZ10-25 ug/mL Thioridazinerespiration

0.570

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.179

menadione6-10 ug/mL Menadionerespiration

-0.072

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.492

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.549

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.266

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.521

NRP_1Non-replicating persistence stage 1dosRassociated

-0.049

Amp0.2mg/mL AmpicillincellWall

-0.016

Cephalexin20-100 ug/mL CephalexincellWall

-0.200

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.008

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.838

EMB10-20 ug/mL EthambutolcellWall

-0.460

Eta12-40 ug/mL EthionamidecellWall

0.276

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.932

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.814

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.348

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.311

BZA0.12 mg/mL BenzamidearomaticAmides

0.309

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.393

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.372

H2O24 mM hydrogen peroxideDNAdamaging

0.116

Levo10 ug/mL LevofloxacinDNAdamaging

0.250

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.150

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.547

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.749

UVUV-irradiationDNAdamaging

-0.237

ARP41-4 ug/mL Antitubercular compound ARP4?

0.380

Antimycin12.5-50 ug/mL Antimycin A?

-0.273

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.192

PA_110-50 ug/mL Antitubercular compound PA-1?

0.376

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.746

PA8240.2-2 ug/mL PA-824?

-0.594

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.011

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.383

Verapamil50 uM Verapamil?

-0.166

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.510

methoxatin10-20 ug/mL Methoxatin?